Conversely, early interventions targeting the NO signaling pathway, including supplementation with L-citrulline [68], NO donors, ADMA-reducing drugs, and enhancement of NOS abundance, demonstrate beneficial effects in mitigating kidney programming-associated offspring hypertension. The gene discussed is NOS2; the disease is hypertensive disorder.